BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18701472)

  • 1. AMP-activated protein kinase signaling results in cytoplasmic sequestration of p27.
    Short JD; Houston KD; Dere R; Cai SL; Kim J; Johnson CL; Broaddus RR; Shen J; Miyamoto S; Tamanoi F; Kwiatkowski D; Mills GB; Walker CL
    Cancer Res; 2008 Aug; 68(16):6496-506. PubMed ID: 18701472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cAMP-dependent cytosolic mislocalization of p27(kip)-cyclin D1 during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.
    Cohen JD; Tham KY; Mastrandrea NJ; Gallegos AC; Monks TJ; Lau SS
    Toxicol Sci; 2011 Aug; 122(2):361-71. PubMed ID: 21693435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin requires AMPK activity and p27 expression for promoting autophagy-dependent Tsc2-null cell survival.
    Campos T; Ziehe J; Fuentes-Villalobos F; Riquelme O; Peña D; Troncoso R; Lavandero S; Morin V; Pincheira R; Castro AF
    Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1200-7. PubMed ID: 26975583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMPK-mediated phosphorylation of murine p27 at T197 promotes binding of 14-3-3 proteins and increases p27 stability.
    Short JD; Dere R; Houston KD; Cai SL; Kim J; Bergeron JM; Shen J; Liang J; Bedford MT; Mills GB; Walker CL
    Mol Carcinog; 2010 May; 49(5):429-39. PubMed ID: 20146253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheb activates AMPK and reduces p27Kip1 levels in Tsc2-null cells via mTORC1-independent mechanisms: implications for cell proliferation and tumorigenesis.
    Lacher MD; Pincheira R; Zhu Z; Camoretti-Mercado B; Matli M; Warren RS; Castro AF
    Oncogene; 2010 Dec; 29(50):6543-56. PubMed ID: 20818424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Akt regulates nuclear/cytoplasmic localization of tuberin.
    Rosner M; Freilinger A; Hengstschläger M
    Oncogene; 2007 Jan; 26(4):521-31. PubMed ID: 16862180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2.
    Soucek T; Yeung RS; Hengstschläger M
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15653-8. PubMed ID: 9861025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMPK/TSC2/mTOR-signaling intermediates are not necessary for LKB1-mediated nuclear retention of PTEN tumor suppressor.
    Liu JL; Mao Z; Gallick GE; Yung WK
    Neuro Oncol; 2011 Feb; 13(2):184-94. PubMed ID: 21123367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberous sclerosis complex suppression in cerebellar development and medulloblastoma: separate regulation of mammalian target of rapamycin activity and p27 Kip1 localization.
    Bhatia B; Northcott PA; Hambardzumyan D; Govindarajan B; Brat DJ; Arbiser JL; Holland EC; Taylor MD; Kenney AM
    Cancer Res; 2009 Sep; 69(18):7224-34. PubMed ID: 19738049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
    Orend G; Hunter T; Ruoslahti E
    Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p42/p44 mitogen-activated protein kinase activation triggers p27Kip1 degradation independently of CDK2/cyclin E in NIH 3T3 cells.
    Delmas C; Manenti S; Boudjelal A; Peyssonnaux C; Eychène A; Darbon JM
    J Biol Chem; 2001 Sep; 276(37):34958-65. PubMed ID: 11418594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis.
    Liang J; Shao SH; Xu ZX; Hennessy B; Ding Z; Larrea M; Kondo S; Dumont DJ; Gutterman JU; Walker CL; Slingerland JM; Mills GB
    Nat Cell Biol; 2007 Feb; 9(2):218-24. PubMed ID: 17237771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p27Kip1 localization depends on the tumor suppressor protein tuberin.
    Rosner M; Freilinger A; Hanneder M; Fujita N; Lubec G; Tsuruo T; Hengstschläger M
    Hum Mol Genet; 2007 Jul; 16(13):1541-56. PubMed ID: 17470459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta induces Cdk2 relocalization to the cytoplasm coincident with dephosphorylation of retinoblastoma tumor suppressor protein.
    Brown KA; Roberts RL; Arteaga CL; Law BK
    Breast Cancer Res; 2004; 6(2):R130-9. PubMed ID: 14979923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic/nuclear localization of tuberin in different cell lines.
    Rosner M; Hengstschläger M
    Amino Acids; 2007 Nov; 33(4):575-9. PubMed ID: 17458623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells.
    Baldassarre G; Belletti B; Bruni P; Boccia A; Trapasso F; Pentimalli F; Barone MV; Chiappetta G; Vento MT; Spiezia S; Fusco A; Viglietto G
    J Clin Invest; 1999 Oct; 104(7):865-74. PubMed ID: 10510327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress.
    Shaw RJ; Kosmatka M; Bardeesy N; Hurley RL; Witters LA; DePinho RA; Cantley LC
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3329-35. PubMed ID: 14985505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AICAR induces phosphorylation of AMPK in an ATM-dependent, LKB1-independent manner.
    Sun Y; Connors KE; Yang DQ
    Mol Cell Biochem; 2007 Dec; 306(1-2):239-45. PubMed ID: 17786544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation.
    Ning J; Clemmons DR
    Mol Endocrinol; 2010 Jun; 24(6):1218-29. PubMed ID: 20363874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma.
    Lu KH; Wu W; Dave B; Slomovitz BM; Burke TW; Munsell MF; Broaddus RR; Walker CL
    Clin Cancer Res; 2008 May; 14(9):2543-50. PubMed ID: 18451215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.